Home genetics startup 23andMe has secured a $1.4 million two-year grant from the National Institutes of Health (NIH) to build survey tools and expand its gene database.
Tags: U.S. Food and Drug Administration
New Drug to Prevent Severe Food Allergies Gets FDA Approval
The US Food and Drug Administration (FDA) has approved a new drug called Xolair that could be life-changing for those with severe food allergies.
Obama to include an additional $1.1 billion to fight drug abuse
President Barrack Obama seeks an additional $1.1 billion in the face of increasing death rates due to overdoses of heroin and opioids. The Obama administration has already split the amount and categorized them to focus on different aspects like increasing medical-assisted facilities, prescriptions of antidotes, plans for overdose prevention, etc. These facilities are to be rolled out to the rural areas as well.
FDA approves new use for Celgene's cancer drug Revlimid
The U.S. Food and Drug Administration has expanded the authorized use of Celgene Corp's cancer drug Revlimid to include newly diagnosed patients with multiple myeloma, the company said on Wednesday.
Vernalis PLC Announces FDA Accepts Tuzistra(TM) XR NDA for Full Review
Vernalis plc and Tris Pharma, Inc. ("Tris") are pleased to announce that the U.S. Food and Drug Administration ("FDA") has confirmed that the New Drug Application ("NDA") for Tuzistra™ XR ("CCP-01") has been accepted for full review. This triggers a milestone payment from Vernalis to Tris.
Latest News
US-based specialty healthcare company Endo Health Solutions Inc agreed to purchase pharmaceutical firm NuPathe Inc in a deal valued at $105 million for its new migraine medication.
1
